Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy

Gabriel Virella, Rickey E. Carter, Antonio Saad, Edward G. Crosswell, B. Andrew Game, Maria F. Lopes-Virella

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Modified lipoproteins are immunogenic and play a key pathogenic role in vascular disease. Antibodies to oxidized LDL (oxLDL) are mostly of the pro-inflammatory IgG1 and IgG3 isotypes. We measured IgG and IgM oxLDL antibodies in immune complexes (IC) isolated from 36 patients with type 1 diabetes using a nested case control design. IgG antibodies predominated over IgM antibodies by an 8:1 ratio. IgG antibody concentrations were higher in the nephropathy cases compared to controls (p = 0.09), but no significant difference was observed because of two patients included in the study who had end-stage renal disease (creatinine > 5 mg/dL and glomerular filtration rate (GFR) less than 17 mL/min). After eliminating these patients from the analysis, significant positive associations of IgG antibody concentration with serum creatinine and albumin excretion rate were observed. Similarly, a negative correlation with estimated glomerular filtration rate was observed in this subsample of 34 patients. Differences in IgM antibody concentrations by nephropathy classification were not supported by the data. In conclusion, the predominance of pro-inflammatory IgG oxLDL antibodies is associated with existence of diabetic nephropathy, and a protective role of IgM antibodies could not be demonstrated.

Original languageEnglish (US)
Pages (from-to)394-400
Number of pages7
JournalClinical Immunology
Volume127
Issue number3
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Antigen-Antibody Complex
Type 1 Diabetes Mellitus
Immunoglobulin M
Immunoglobulin G
Antibodies
Glomerular Filtration Rate
Creatinine
oxidized low density lipoprotein
low density lipoprotein inhibitor
Diabetic Nephropathies
Vascular Diseases
Serum Albumin
Lipoproteins
Chronic Kidney Failure

Keywords

  • Autoimmunity
  • Diabetes
  • Immune complexes
  • Nephropathy
  • Oxidized LDL antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Medicine(all)

Cite this

Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. / Virella, Gabriel; Carter, Rickey E.; Saad, Antonio; Crosswell, Edward G.; Game, B. Andrew; Lopes-Virella, Maria F.

In: Clinical Immunology, Vol. 127, No. 3, 01.06.2008, p. 394-400.

Research output: Contribution to journalArticle

Virella, Gabriel ; Carter, Rickey E. ; Saad, Antonio ; Crosswell, Edward G. ; Game, B. Andrew ; Lopes-Virella, Maria F. / Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy. In: Clinical Immunology. 2008 ; Vol. 127, No. 3. pp. 394-400.
@article{28285d6646ad4ce38a5d7f72dbc1f2d5,
title = "Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy",
abstract = "Modified lipoproteins are immunogenic and play a key pathogenic role in vascular disease. Antibodies to oxidized LDL (oxLDL) are mostly of the pro-inflammatory IgG1 and IgG3 isotypes. We measured IgG and IgM oxLDL antibodies in immune complexes (IC) isolated from 36 patients with type 1 diabetes using a nested case control design. IgG antibodies predominated over IgM antibodies by an 8:1 ratio. IgG antibody concentrations were higher in the nephropathy cases compared to controls (p = 0.09), but no significant difference was observed because of two patients included in the study who had end-stage renal disease (creatinine > 5 mg/dL and glomerular filtration rate (GFR) less than 17 mL/min). After eliminating these patients from the analysis, significant positive associations of IgG antibody concentration with serum creatinine and albumin excretion rate were observed. Similarly, a negative correlation with estimated glomerular filtration rate was observed in this subsample of 34 patients. Differences in IgM antibody concentrations by nephropathy classification were not supported by the data. In conclusion, the predominance of pro-inflammatory IgG oxLDL antibodies is associated with existence of diabetic nephropathy, and a protective role of IgM antibodies could not be demonstrated.",
keywords = "Autoimmunity, Diabetes, Immune complexes, Nephropathy, Oxidized LDL antibodies",
author = "Gabriel Virella and Carter, {Rickey E.} and Antonio Saad and Crosswell, {Edward G.} and Game, {B. Andrew} and Lopes-Virella, {Maria F.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1016/j.clim.2008.02.005",
language = "English (US)",
volume = "127",
pages = "394--400",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy

AU - Virella, Gabriel

AU - Carter, Rickey E.

AU - Saad, Antonio

AU - Crosswell, Edward G.

AU - Game, B. Andrew

AU - Lopes-Virella, Maria F.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Modified lipoproteins are immunogenic and play a key pathogenic role in vascular disease. Antibodies to oxidized LDL (oxLDL) are mostly of the pro-inflammatory IgG1 and IgG3 isotypes. We measured IgG and IgM oxLDL antibodies in immune complexes (IC) isolated from 36 patients with type 1 diabetes using a nested case control design. IgG antibodies predominated over IgM antibodies by an 8:1 ratio. IgG antibody concentrations were higher in the nephropathy cases compared to controls (p = 0.09), but no significant difference was observed because of two patients included in the study who had end-stage renal disease (creatinine > 5 mg/dL and glomerular filtration rate (GFR) less than 17 mL/min). After eliminating these patients from the analysis, significant positive associations of IgG antibody concentration with serum creatinine and albumin excretion rate were observed. Similarly, a negative correlation with estimated glomerular filtration rate was observed in this subsample of 34 patients. Differences in IgM antibody concentrations by nephropathy classification were not supported by the data. In conclusion, the predominance of pro-inflammatory IgG oxLDL antibodies is associated with existence of diabetic nephropathy, and a protective role of IgM antibodies could not be demonstrated.

AB - Modified lipoproteins are immunogenic and play a key pathogenic role in vascular disease. Antibodies to oxidized LDL (oxLDL) are mostly of the pro-inflammatory IgG1 and IgG3 isotypes. We measured IgG and IgM oxLDL antibodies in immune complexes (IC) isolated from 36 patients with type 1 diabetes using a nested case control design. IgG antibodies predominated over IgM antibodies by an 8:1 ratio. IgG antibody concentrations were higher in the nephropathy cases compared to controls (p = 0.09), but no significant difference was observed because of two patients included in the study who had end-stage renal disease (creatinine > 5 mg/dL and glomerular filtration rate (GFR) less than 17 mL/min). After eliminating these patients from the analysis, significant positive associations of IgG antibody concentration with serum creatinine and albumin excretion rate were observed. Similarly, a negative correlation with estimated glomerular filtration rate was observed in this subsample of 34 patients. Differences in IgM antibody concentrations by nephropathy classification were not supported by the data. In conclusion, the predominance of pro-inflammatory IgG oxLDL antibodies is associated with existence of diabetic nephropathy, and a protective role of IgM antibodies could not be demonstrated.

KW - Autoimmunity

KW - Diabetes

KW - Immune complexes

KW - Nephropathy

KW - Oxidized LDL antibodies

UR - http://www.scopus.com/inward/record.url?scp=45249087013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45249087013&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2008.02.005

DO - 10.1016/j.clim.2008.02.005

M3 - Article

VL - 127

SP - 394

EP - 400

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -